Nine (23.7%) of the 38 patients with MAP3K3 somatic mutations presented with symptomatic events and corresponding overt intracerebral hemorrhage on the magnetic resonance imaging (MRI), whereas 11(91.7%) of the 12 patients with CCM gene somatic mutations exhibited overt intracerebral hemorrhage (13). Here, MAP3K3 is linked to intracerebral hemorrhage.